NorthWest Biotherapeutics Inc (NWBO)

[Evaluate]

You wrote:

my personal inclination was that this board would ignore the very hopeful sign that Dr. Hahn might be the FDA's next lead. I have no doubt many here know his background is intimately tied to a University that supports Autologous dendritic therapy, and said University indeed worked with Dr. Bosch and DCVax-L on a small but very successful ovarian trial (pilot study).

I did not see anything why it would be a “very hopeful sign” if Dr Stephen Hahn becomes FDA next lead. It appears to be that his background is more in regards to radiation oncology. I did not see that he has any involvement, experience or enthusiasm for dendritic cell treatments. Merely the fact that he worked at that University does not make me “very hopeful”.